Establishing a Medical Tourism Facilitation Company in Nigeria: A Strategic Investment Guide

Establishing a Medical Tourism Facilitation Company in Nigeria: A Strategic Investment Guide provides a comprehensive, data-driven assessment of one of the most rapidly expanding and structurally embedded segments of Nigeria’s healthcare economy — outbound medical travel.

Each year, an estimated 15,000 to 25,000 Nigerians travel abroad for medical care, seeking treatment in destinations such as India, the United Kingdom, the United States, South Africa, Germany, Turkey, and Thailand. These journeys span a wide spectrum of high-value healthcare services, including cardiac and neurosurgery, organ transplantation, oncology care, in-vitro fertilisation (IVF), orthopaedic procedures, advanced diagnostics, and specialised dental and reconstructive treatments. Conservative estimates place Nigeria’s annual outbound medical expenditure at between USD 1.2 billion and USD 2.0 billion, positioning the country among the largest sources of medical tourism demand in sub-Saharan Africa and a significant contributor globally.

This sustained outflow of healthcare spending is driven by deep structural constraints within Nigeria’s domestic health system, including insufficient specialist infrastructure, chronic underinvestment in public healthcare facilities, erosion of public trust in health institutions, and the ongoing migration of highly skilled medical professionals to more developed healthcare systems abroad. At the same time, rising incomes among Nigeria’s middle and upper classes have increased the ability of households to finance international treatment, reinforcing a long-term demand cycle for overseas healthcare services.

Within this context, medical tourism facilitation companies have emerged as critical intermediaries in the healthcare value chain. These firms provide end-to-end coordination for patients seeking treatment abroad, including hospital selection and specialist matching, remote medical record review, appointment scheduling, visa processing, travel and accommodation logistics, financial coordination, and patient support throughout the treatment journey. By simplifying what is often a complex, fragmented, and emotionally demanding process, facilitation companies significantly reduce friction, risk, and uncertainty for patients and their families.

This investment guide, prepared by Foraminifera Market Research Limited, presents a detailed examination of the opportunity to establish a medical tourism facilitation company in Nigeria in 2026. It evaluates the market size and growth dynamics, competitive landscape, operational model design, regulatory considerations, revenue structures, and financial viability. The analysis demonstrates that the sector offers a capital-light, service-driven investment opportunity with strong scalability potential, minimal infrastructure requirements, and the ability to generate attractive returns by bridging Nigeria’s expanding outbound patient demand with global healthcare providers.

Table of Contents

Chapter One: Introduction and Business Overview Chapter Two: Industry Analysis and Market Overview Chapter Three: Market Analysis and Commercial Opportunities Chapter Four: Business Model, Operations and Service Delivery Chapter Five: Legal, Regulatory and Risk Management Framework Chapter Six: Technical, Infrastructure and Technology Requirements Chapter Seven: Financial Analysis and Investment Appraisal Chapter Eight: Implementation Roadmap and Strategic Recommendations Appendices

Get this Report

Direct bank transfer

To order the report, Please do pay the sum of ₦350,000 into